Scientific Sessions 2024  /  Substance Use and Cardiovascular Risk 1  /  The Effects of Illicit Drug Use on Congestive Heart Failure Patients and Hospital Readmission Rates at Harlem Hospital Center
Logo

American Heart Association

  10
  0

Final ID: Sa3141

The Effects of Illicit Drug Use on Congestive Heart Failure Patients and Hospital Readmission Rates at Harlem Hospital Center

Abstract Body (Do not enter title and authors here): Introduction: CHF is defined as a chronic disease that impacts more than 5 million adults in the United States with significant population-wide impact on morbidity, mortality and hospitalization burden, especially amonth high-risk and vulnerable populations. Although the intricacies of CHF and readmission risk have been well documented, there have been fewer studies investigating the effect of illicit drug use on CHF patients and readmission outcomes especially in a population at high risk of health disparities.
Objective: The purpose of this study was to examine the effects of illicit drug use on CHF patients and hospital readmission rates at Harlem Hospital Center with a high density of patients with health disparities.
Methods: We included all patients admitted during a 2 year period (2019-2020) with a primary diagnosis of heart failure to Harlem Hospital Center and conducted in depth assessment of drug use history including patient history, available laboratory analysis, and collateral EMR information. Rehospitalization was assessed by review of EMR by trained medical professionals. Our results were analyzed using standard statistical methods between the two groups with and without history of drug use.
Results: Our study population included 380 admitted CHF patients. The overall prevalence of illicit drug use in CHF patients was 32.89%, with the most common drug used being cocaine. CHF patients who used illicit drugs had a 22.58% 30-day readmission rate in comparison to 13.78% among CHF patients who didn’t use illicit drugs. In addition, CHF patients who used illicit drugs had higher all-time hospitalizations and were more likely to be admitted than non-illicit drug users in terms of heart failure hospitalizations. Overall, CHF patients who used any type of illicit drug were twice as likely to be readmitted after index hospitalization compared to CHF patients who didn’t use illicit drugs. We also found that CHF patients who used illicit drugs were slightly younger, more likely to be male, and more likely to smoke cigarettes. Lastly, we observed that at least 50% of CHF patients who used illicit drugs were on government assistance, lacked family support, and were unemployed.
Conclusion: Drug use is a common problem among patients with CHF in this vulnerable population and is associated with significant adverse outcomes such as increased rehospitalization. Systemic efforts to address this at the patient and community level are justified.
  • Majdalani, Rosemarie  ( Institute of Human Nutrition , New York , New York , United States )
  • Kwentoh, Ifeoma  ( Harlem Hospital Center , New York , New York , United States )
  • Roy, Pooja  ( Harlem Hospital Center , New York , New York , United States )
  • Dulal, Subash  ( Harlem Hospital Center , New York , New York , United States )
  • Jha, Sapana  ( Harlem Hospital Center , New York , New York , United States )
  • Shou, Jialu  ( Institute of Human Nutrition , New York , New York , United States )
  • Rijhwani, Simran  ( Institute of Human Nutrition , New York , New York , United States )
  • Ionescu, Natalia  ( Harlem Hospital Center , New York , New York , United States )
  • Kakade, Meghana  ( Harlem Hospital Center , New York , New York , United States )
  • Kurian, Damian  ( Harlem Hospital Center , New York , New York , United States )
  • Raiszadeh, Farbod  ( Harlem Hospital Center , New York , New York , United States )
  • Magdits, Mariel  ( UCSF , San Francisco , California , United States )
  • Alshammari, Asmaa  ( Institute of Human Nutrition , New York , New York , United States )
  • Hughes, Anna  ( Institute of Human Nutrition , New York , New York , United States )
  • Mccann, Lily  ( Institute of Human Nutrition , New York , New York , United States )
  • Devarajan, Sriraman  ( Harlem Hospital Center , New York , New York , United States )
  • Thu, Myint  ( Harlem Hospital Center , New York , New York , United States )
  • Jameel, Ihab  ( Harlem Hospital Center , New York , New York , United States )
  • Mangeshkar, Shaunak  ( Harlem Hospital Center , New York , New York , United States )
    • Author Disclosures:
    Rosemarie Majdalani: DO NOT have relevant financial relationships | Ifeoma Kwentoh: No Answer | Pooja Roy: DO NOT have relevant financial relationships | Subash Dulal: No Answer | Sapana Jha: No Answer | Jialu Shou: No Answer | Simran Rijhwani: DO NOT have relevant financial relationships | Natalia Ionescu: No Answer | Meghana Kakade: No Answer | Damian Kurian: No Answer | Farbod Raiszadeh: DO NOT have relevant financial relationships | Mariel Magdits: DO NOT have relevant financial relationships | Asmaa Alshammari: DO NOT have relevant financial relationships | Anna Hughes: No Answer | Lily McCann: DO NOT have relevant financial relationships | Sriraman Devarajan: No Answer | Myint Thu: No Answer | Ihab Jameel: No Answer | Shaunak Mangeshkar: No Answer
Meeting Info:

Scientific Sessions 2024

2024

Chicago, Illinois

Session Info:

Substance Use and Cardiovascular Risk 1

Saturday, 11/16/2024 , 10:30AM - 11:30AM

Abstract Poster Session

More abstracts on this topic:
A Pilot Study Of Dopaminergic Enhancement Of Rehabilitation Therapy Early After Stroke

Cramer Steven, Ventoza Cristina, Shklanko Lauren, Stehman Andrea, Soleimani Nina, Kras Genevieve, Young Brittany, Roberts Pamela, Song Min-keun, Chang Tracy, Su Michael, Brinkman Lorie, Gornbein Jeffrey, Le Vu, Holl Christina, Cardoso Ferreira Isabel, Atkinson Megan, Ha Kara, Nguyen Tiffany, Schwarz Anne, Feldman Marc

5-oxoproline/ OPLAH Axis Alleviates Doxorubicin-induced Cardiomyopathy By Inhibiting Ferroptosis

Jiang Meng, Guo Xinning

More abstracts from these authors:
The prevalence of transthyretin cardiac amyloidosis in older Black and Hispanic individuals with heart failure: The Screening for Cardiac Amyloidosis with Nuclear imaging in Minority Populations Study

Ruberg Frederick, Blaner William, Deluca Albert, Johnson Lynne, Kinkhabwala Mona, Leb Jay, Mintz Akiva, Lavalley Michael, Einstein Andrew, Cohn Elizabeth, Kelly Jeffery, Teruya Sergio, Miller Edward, Maurer Mathew, Helmke Stephen, Fine Denise, Kurian Damian, Raiszadeh Farbod, Connors Lawreen, Prokaeva Tatiana, Pandey Shivda

Health Literacy Exacerbates Neighborhood Social Vulnerability in Older Black and Hispanic Adults with Heart Failure: Results from the SCAN-MP Study

Islam Shabatun, De Freitas Cinthia, Kurian Damian, Ionescu Natalia, Janvier Ivrose, Raiszadeh Farbod, Magnani Jared, Maurer Mathew, Ruberg Frederick, Teruya Sergio, Fine Denise, Sabogal Natalia, Fils Sergylensky, Ullah Ikram, Sanchorawala Anya, Miller Edward, Gallegos Cesia

You have to be authorized to contact abstract author. Please, Login
Not Available